The definition of 'released' is very strict, requiring availability for purchase or paid preorder by the general public, excluding demos or non-paid waitlists. This differs significantly from a standard product unveiling. Additionally, the options list Dec 31 and June 30, but the rule text focuses on the June 30th deadline, creating potential confusion regarding the specific cutoff date for resolution versus the market expiration date.

This event is directly tied to Tesla (TSLA) delivering on the AI and robotics narrative supporting its high valuation. A successful public release of Optimus would be a massive technical milestone, likely causing significant stock appreciation (Score 4). Conversely, delays could hurt investor confidence. This volatility might have a minor spillover effect on the tech-heavy Nasdaq 100.

There is a significant divergence between the market price and mainstream technological consensus. Mainstream robotics experts and Wall Street analysts generally agree that even with Musk's aggressive timelines, commercialization and public sales of consumer-grade humanoid robots will not occur until well after 2027, with 2026 limited to internal and small-scale industrial pilots. However, the market still assigns an 18.5% probability to a 'release before the end of 2026', reflecting a blind premium paid by retail bettors for the 'Musk effect', failing to strictly differentiate between 'internal production' and 'public paid pre-orders' which is a decisive factor under the market rules.